RX360
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RX360 Trademark

Serial Number: 90788819 • Registration: 6875503

RX360 is a trademark filed by Rx-360 International Pharmaceutical Supply Chain Consortium on June 22, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Rx-360 International Pharmaceutical Supply Chain Consortium (10 trademarks)

1617 JFK Blvd
Philadelphia, PA 19103

Entity Type: 99

Trademark Details

Filing Date

June 22, 2021

Registration Date

October 18, 2022

Published for Opposition

August 2, 2022

Goods & Services

Educational services, namely, providing seminars, symposia, and workshops in the field of pharmaceutical supply chain security; providing non-downloadable webinars in the field of pharmaceutical supply chain security

Downloadable electronic publications, namely, white papers, model forms, audit guidelines, and reports in the field of pharmaceutical supply chain security

Printed materials, namely, white papers, model forms, audit guidelines, and reports in the field of pharmaceutical supply chain security

Association services, namely, organizing a consortium in the field of pharmaceutical supply chain security and promoting the interests of members thereof; promoting the interests of biotechnology, pharmaceutical and generic drug manufacturers, suppliers, wholesalers and distributors in the field of pharmaceutical supply chain security

Organizing and conducting a product safety auditing program of pharmaceutical suppliers and pharmaceutical ingredient suppliers for technical analysis and evaluation of potential risks and safeguards; Pharmaceutical product safety auditing; Medical device product safety auditing; Organizing and conducting supply chain product safety audits in the field of pharmaceuticals; Organizing and conducting supply chain product safety audits in the field of medical devices; Organizing and conducting a product safety auditing program of pharmaceutical manufacturers and suppliers, pharmaceutical ingredient manufacturers and suppliers and medical device manufacturers and suppliers for technical analysis and evaluation of potential risks and safeguards in real time and in a confidential manner; Providing a website featuring technology which provides users with the ability to access a database to organize and conduct supply chain audits in the field of pharmaceuticals and medical devices in real time and in a confidential manner

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 4, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 4, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 4, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 4, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 4, 2023 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 18, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 18, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 2, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 2, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 13, 2022 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 12, 2022 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 30, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2022 CRFA
ASSIGNED TO LIE
Mar 30, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 25, 2022 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 21, 2022 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 21, 2022 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Mar 21, 2022 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Mar 21, 2022 CPEA
ASSIGNED TO EXAMINER
Mar 12, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 8, 2021 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 7, 2021 NWOS
NEW APPLICATION ENTERED
Jun 25, 2021 NWAP